Schedule 13D ownership disclosure

EPIRUS BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 29428P107

Event date: 2014-07-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,179,095
Percent of class
16.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-053283
Form type
SC 13D
Filer
5AM VENTURES III, L.P.
CIK
CIK 1456890
Filed
Aug 29, 2014
Reporting period
Jul 15, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub